These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23001181)

  • 1. Annotating MYC status with 89Zr-transferrin imaging.
    Holland JP; Evans MJ; Rice SL; Wongvipat J; Sawyers CL; Lewis JS
    Nat Med; 2012 Oct; 18(10):1586-91. PubMed ID: 23001181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive
    Henry KE; Dilling TR; Abdel-Atti D; Edwards KJ; Evans MJ; Lewis JS
    J Nucl Med; 2018 Jan; 59(1):51-57. PubMed ID: 28848040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying ⁸⁹Zr-Transferrin To Study the Pharmacology of Inhibitors to BET Bromodomain Containing Proteins.
    Doran MG; Carnazza KE; Steckler JM; Spratt DE; Truillet C; Wongvipat J; Sawyers CL; Lewis JS; Evans MJ
    Mol Pharm; 2016 Feb; 13(2):683-8. PubMed ID: 26725682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A PET Imaging Strategy for Interrogating Target Engagement and Oncogene Status in Pancreatic Cancer.
    Henry KE; Dacek MM; Dilling TR; Caen JD; Fox IL; Evans MJ; Lewis JS
    Clin Cancer Res; 2019 Jan; 25(1):166-176. PubMed ID: 30228208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the internal epitope of prostate-specific membrane antigen with 89Zr-7E11 immuno-PET.
    Ruggiero A; Holland JP; Hudolin T; Shenker L; Koulova A; Bander NH; Lewis JS; Grimm J
    J Nucl Med; 2011 Oct; 52(10):1608-15. PubMed ID: 21908391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annotating STEAP1 regulation in prostate cancer with 89Zr immuno-PET.
    Doran MG; Watson PA; Cheal SM; Spratt DE; Wongvipat J; Steckler JM; Carrasquillo JA; Evans MJ; Lewis JS
    J Nucl Med; 2014 Dec; 55(12):2045-9. PubMed ID: 25453051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnitude of enhanced permeability and retention effect in tumors with different phenotypes: 89Zr-albumin as a model system.
    Heneweer C; Holland JP; Divilov V; Carlin S; Lewis JS
    J Nucl Med; 2011 Apr; 52(4):625-633. PubMed ID: 21421727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-Time Transferrin-Based PET Detects MYC-Positive Prostate Cancer.
    Aggarwal R; Behr SC; Paris PL; Truillet C; Parker MFL; Huynh LT; Wei J; Hann B; Youngren J; Huang J; Premasekharan G; Ranatunga N; Chang E; Gao KT; Ryan CJ; Small EJ; Evans MJ
    Mol Cancer Res; 2017 Sep; 15(9):1221-1229. PubMed ID: 28592703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of prostate cancer with immuno-PET and immuno-SPECT using a radiolabeled anti-EGP-1 monoclonal antibody.
    van Rij CM; Sharkey RM; Goldenberg DM; Frielink C; Molkenboer JD; Franssen GM; van Weerden WM; Oyen WJ; Boerman OC
    J Nucl Med; 2011 Oct; 52(10):1601-7. PubMed ID: 21865288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immuno-PET Imaging of CD30-Positive Lymphoma Using 89Zr-Desferrioxamine-Labeled CD30-Specific AC-10 Antibody.
    Rylova SN; Del Pozzo L; Klingeberg C; Tönnesmann R; Illert AL; Meyer PT; Maecke HR; Holland JP
    J Nucl Med; 2016 Jan; 57(1):96-102. PubMed ID: 26514172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancer.
    Yang G; Goltsov AA; Ren C; Kurosaka S; Edamura K; Logothetis R; DeMayo FJ; Troncoso P; Blando J; DiGiovanni J; Thompson TC
    Mol Cancer Res; 2012 Feb; 10(2):218-29. PubMed ID: 22144662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine.
    Vosjan MJ; Perk LR; Visser GW; Budde M; Jurek P; Kiefer GE; van Dongen GA
    Nat Protoc; 2010 Apr; 5(4):739-43. PubMed ID: 20360768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells.
    Iwata T; Schultz D; Hicks J; Hubbard GK; Mutton LN; Lotan TL; Bethel C; Lotz MT; Yegnasubramanian S; Nelson WG; Dang CV; Xu M; Anele U; Koh CM; Bieberich CJ; De Marzo AM
    PLoS One; 2010 Feb; 5(2):e9427. PubMed ID: 20195545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical evaluation of ⁸⁹Zr-labeled human antitransferrin receptor monoclonal antibody as a PET probe using a pancreatic cancer mouse model.
    Sugyo A; Tsuji AB; Sudo H; Nagatsu K; Koizumi M; Ukai Y; Kurosawa G; Zhang MR; Kurosawa Y; Saga T
    Nucl Med Commun; 2015 Mar; 36(3):286-94. PubMed ID: 25460304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerenkov luminescence imaging of medical isotopes.
    Ruggiero A; Holland JP; Lewis JS; Grimm J
    J Nucl Med; 2010 Jul; 51(7):1123-30. PubMed ID: 20554722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bioconjugation and radiosynthesis of 89Zr-DFO-labeled antibodies.
    Zeglis BM; Lewis JS
    J Vis Exp; 2015 Feb; (96):. PubMed ID: 25741890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploitation of CD133 for the Targeted Imaging of Lethal Prostate Cancer.
    Glumac PM; Gallant JP; Shapovalova M; Li Y; Murugan P; Gupta S; Coleman IM; Nelson PS; Dehm SM; LeBeau AM
    Clin Cancer Res; 2020 Mar; 26(5):1054-1064. PubMed ID: 31732520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30.
    Perk LR; Stigter-van Walsum M; Visser GW; Kloet RW; Vosjan MJ; Leemans CR; Giaccone G; Albano R; Comoglio PM; van Dongen GA
    Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1857-67. PubMed ID: 18491091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging.
    Perk LR; Vosjan MJ; Visser GW; Budde M; Jurek P; Kiefer GE; van Dongen GA
    Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):250-9. PubMed ID: 19763566
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.